Results of Tender Offer for acquisition of minority shares of Cadista Holdings Inc.
Jubilant Life Sciences Ltd has submitted to BSE regarding a Press Release dated December 23, 2014 titled "Results of Tender Offer for acquisition of minority shares of Cadista Holdings Inc." Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Tender Offer by Jubilant Pharma Ltd, a subsidiary of Jubilant Life Sciences Ltd
Jubilant Life Sciences Ltd has informed BSE that Jubilant Pharma Limited ("JPL"), a Singapore company and wholly-owned subsidiary of Jubilant Life Sciences Limited, through Jubilant Generics Inc., a Delaware corporation and an indirect wholly-owned subsidiary of JPL, ("Jubilant Generics") has commenced a Tender Offer to acquire all outstanding shares of common stock (collectively, the "Shares") of Cadista Holdings Inc., a Delaware corporation ("Cadista"),... Announces Q2 results, Results Press Release & Limited Review Report for the Quarter ended September 30, 2014
Jubilant Life Sciences Ltd has announced the following results for the quarter ended September 30, 2014:"The Unaudited Standalone results for the Quarter ended September 30, 2014The Company has posted a net profit of Rs. 2167.60 million for the quarter ended September 30, 2014 where as the same was at net loss of Rs. (785.80) million for the quarter ended September 30, 2013. Total Income is Rs. 7530.30 million for the quarter ended... Q2 results on Oct 28, 2014
Jubilant Life Sciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 28, 2014, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2014 (Q2).Further, as per the Company's Insider Trading Code, the Trading Window for dealing in the securities of the Company would remain closed for all Directors/Officers/Designated Employees... Shareholding Pattern For September 30, 2014
Jubilant Life Sciences Ltd has informed BSE about the Shareholding Pattern as on September 30, 2014. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jubilant Stock Holding Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Updates on Resignation of Directors
With reference to the earlier announcement dated September 23, 2014 regarding resignation of Dr. Inder Mohan Vermaand Mr. Suresh Kumar as Directors from the Board of Jubilant Life Sciences Ltd.Jubilant Life Sciences Ltd has now informed BSE that both of them are proposed to be appointed as Directors of Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of the Company. Resignation of Director
Jubilant Life Sciences Ltd has informed BSE that Mr. Abhay Havaldar has resigned as Director from the Board of the Company with effect from September 24, 2014.